Enhanced oxidative stress and platelet activation in patients with Cushing's syndrome

Clinical Endocrinology

Volumn 82, Issue 4, 2015, Pages 517-524

  Karamouzis, Ioannis ^a   Berardelli, Rita ^a   D'Angelo, Valentina ^a   Fussotto, Beatrice ^a   Zichi, Clizia ^a   Giordano, Roberta ^b   Settanni, Fabio ^a   Maccario, Mauro ^a   Ghigo, Ezio ^a   Arvat, Emanuela ^b  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; ISOPROSTANE DERIVATIVE; THROMBOXANE B2; 15-F2ALPHA-ISOPROSTANE; ANTIOXIDANT; HORMONE; OXIDIZING AGENT;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CUSHING SYNDROME; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; VITAMIN BLOOD LEVEL; ANTHROPOMETRY; ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASE; CHEMISTRY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; ANTHROPOMETRY; ANTIOXIDANTS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CUSHING SYNDROME; FEMALE; GLUCOSE; HORMONES; HUMANS; ISOPROSTANES; MALE; MIDDLE AGED; OXIDANTS; OXIDATIVE STRESS; PLATELET ACTIVATION; THROMBOXANE B2; VITAMIN E;

EID: 84924199825     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12524     Document Type: Article

References (35)

1. Bertagna, X., Guignat, L., Groussin, L., et al,. (2009) Cushing's disease. Best Practice & Research. Clinical Endocrinology & Metabolism, 23, 607-623.
2. Graversen, D., Vestergaard, P., Stochholm, K., et al,. (2012) Mortality in Cushing's syndrome: a systematic review and meta-analysis. European Journal of Internal Medicine, 23, 278-282.
3. Colao, A., Pivonello, R., Spiezia, S., et al,. (1999) Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. Journal of Clinical Endocrinology and Metabolism, 84, 2664-2672.
4. Lee, R., Margaritis, M., Channon, K.M., et al,. (2012) Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Current Medical Chemistry, 19, 2504-2520.
5. Morrow, J.D., (2005) Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arteriosclerosis, Thrombosis and Vascular Biology, 25, 279-286.
6. Montuschi, P., Barnes, P.J., &, Roberts, L.J. 2nd., (2004) Isoprostanes: markers and mediators of oxidative stress. FASEB Journal, 18, 1791-1800.
7. Hayden, M.R., Whaley-Connell, A., &, Sowers, J.R., (2005) Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic nephropathy: paying homage to the podocyte. American Journal of Nephrology, 25, 553-569.
8. Marumo, T., Schini-Kerth, V., Brandes, R., et al,. (1998) Glucocorticoids inhibit superoxide anion production and p22 Phox mRNA expression in human aortic smooth muscle cells. Hypertension, 32, 1083-1088.
9. Rizzoni, D., Porteri, E., De Ciuceis, C., et al,. (2009) Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism, 94, 5010-5018.
10. Prázný, M., Jezková, J., Horová, E., et al,. (2008) Impaired microvascular reactivity and endothelial function in patients with Cushing's syndrome: influence of arterial hypertension. Physiological Research, 57, 13-22.
11. Zhang, Y., Croft, K.D., Mori, T.A., et al,. (2004) The antioxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat. American Journal of Hypertension, 17, 260-265.
12. Cracowski, J.L., Durand, T., &, Bessard, G., (2002) Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends in Pharmacological Sciences, 23, 360-366.
13. Roberts, L.J., &, Morrow, J.D., (2000) Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radical Biology and Medicine, 28, 505-513.
14. Karamouzis, I., Pervanidou, P., Berardelli, R., et al,. (2011) Enhanced oxidative stress and platelet activation combined with reduced antioxidant capacity in obese prepubertal and adolescent girls with full or partial metabolic syndrome. Hormone and Metabolic Research, 43, 607-613.
15. Nakahata, N., (2008) Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology. Pharmacology & Therapeutics, 118, 18-35.
16. Davì, G., Ciabattoni, G., Consoli, A., et al,. (1999) In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation, 99, 224-229.
17. Guagnano, M.T., Ferroni, P., Santilli, F., et al,. (2009) Determinants of platelet activation in hypertensives with microalbuminuria. Free Radical Biology & Medicine, 46, 922-927.
18. Karamouzis, I., Sarafidis, P.A., Karamouzis, M., et al,. (2008) Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. American Journal of Nephrology, 28, 397-404.
19. Mohn, A., Catino, M., Capanna, R., et al,. (2005) Increased oxidative stress in prepubertal severely obese children: effect of a dietary restriction-weight loss program. Journal of Clinical Endocrinology and Metabolism, 90, 2653-2658.
20. Suksomboon, N., Poolsup, N., &, Sinprasert, S., (2011) Effects of vitamin E supplementation on glycaemic control in type 2 diabetes: systematic review of randomized controlled trials. Journal of Clinical Pharmacy and Therapeutics, 36, 53-63.
21. Freedman, J.E., Farhat, J.H., Loscalzo, J., et al,. (1996) Alfa-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation, 94, 2434-2440.
22. Koh, K.K., Oh, P.C., &, Quon, M.J., (2009) Does reversal of oxidative stress and inflammation provide vascular protection? Cardiovascular Research, 81, 649-659.
23. Gönenç, A., Hacişevki, A., Aslan, S., et al,. (2012) Oxidative stress in patients with essential hypertension: a comparison of dippers and non-dipper. European Journal of Internal Medicine, 23, 350-354.
24. Stephens, J.W., Gable, D.R., Hurel, S.J., et al,. (2006) Increased plasma markers of oxidative stress are associated with coronary heart disease in males with diabetes mellitus and with 10-year risk in a prospective sample of males. Clinical Chemistry, 52, 446-452.
25. Stephens, J.W., Khanolkar, M.P., &, Bain, S.C., (2009) The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis, 202, 321-329.
26. Nieman, L.K., Biller, B.M., Findling, J.W., et al,. (2008) The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 93, 1526-1540.
27. Whitworth, J.A., (2003) World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension, 21, 1983-1992.
28. Alberti, K.G., &, Zimmet, P.Z., (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Medicine, 15, 539-553.
29. American Diabetes Association (2012) Standards of medical care in diabetes-2012. Diabetes Care, 35 (Suppl 1), S11-S63.
30. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2012) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106, 3143-3421.
31. Kanis, J.A., Melton, L.J. 3rd, Christiansen, C., et al,. (1994) The diagnosis of osteoporosis. Journal of Bone and Mineral Research, 9, 1137-1141.
32. Binkley, N., Bilezikian, J.P., Kendler, D.L., et al,. (2007) Summary of the International Society For Clinical Densitometry 2005 Position Development Conference. Journal of Bone and Mineral Research, 22, 643-645.
33. Davì, G., Guagnano, M.T., Ciabattoni, G., et al,. (2002) Platelet activation in obese women: role of inflammation and oxidant stress. JAMA, 288, 2008-2014.
34. Vincent, H.K., &, Taylor, A.G., (2006) Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. International Journal of Obesity, 30, 400-418.
35. Urakawa, H., Katsuki, A., Sumida, Y., et al,. (2003) Oxidative stress is associated with adiposity and insulin resistance in men. Journal of Clinical Endocrinology and Metabolism, 88, 4673-4676.